
Empress Therapeutics is a pioneering biotechnology company revolutionizing small molecule drug discovery by leveraging genetic data, artificial intelligence, and synthetic biology. Their Chemilogics™ platform enables the rapid identification of novel drug candidates sourced from within the human body, significantly accelerating the drug development process. By utilizing co-evolution and AI/ML, Empress aims to unlock millions of new chemical compounds, making the discovery of effective and safe medicines more predictable and efficient. The company is positioned at the forefront of the biotech industry, addressing serious unmet medical needs with innovative solutions.

Empress Therapeutics is a pioneering biotechnology company revolutionizing small molecule drug discovery by leveraging genetic data, artificial intelligence, and synthetic biology. Their Chemilogics™ platform enables the rapid identification of novel drug candidates sourced from within the human body, significantly accelerating the drug development process. By utilizing co-evolution and AI/ML, Empress aims to unlock millions of new chemical compounds, making the discovery of effective and safe medicines more predictable and efficient. The company is positioned at the forefront of the biotech industry, addressing serious unmet medical needs with innovative solutions.